Inactive Instrument
Probi AB Stock OTC Markets
Stocks
PBBIF
SE0001280355
Pharmaceuticals
OTC Markets Traded| 1 day | +31.67% |
| Manager | Title | Age | Since |
|---|---|---|---|
Anita Johansen
CEO | Chief Executive Officer | 54 | 2022-12-07 |
Johan Flink
DFI | Director of Finance/CFO | 49 | 2025-07-31 |
James Henson
COO | Chief Operating Officer | 39 | 2024-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jörn Andreas
BRD | Director/Board Member | 45 | 2013-12-31 |
| Chairman | 62 | 2015-03-31 | |
| Director/Board Member | 64 | 2017-05-03 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +31.67% | +85.88% | - | - | 33.68M | ||
| +0.09% | +2.12% | +56.49% | +169.19% | 1,084B | ||
| -1.63% | +2.02% | +66.31% | +62.70% | 634B | ||
| -1.12% | -0.46% | +31.69% | +84.44% | 447B | ||
| +0.18% | +2.04% | +30.19% | +26.51% | 330B | ||
| -6.22% | -3.61% | +29.15% | +32.09% | 295B | ||
| -1.27% | -0.56% | +27.21% | +46.39% | 285B | ||
| -0.93% | -1.19% | -28.85% | -40.38% | 218B | ||
| -1.19% | +0.63% | +22.43% | +66.30% | 199B | ||
| -0.72% | +7.04% | +21.41% | +81.19% | 169B | ||
| Average | +2.23% | +2.52% | +28.45% | +58.71% | 406.65B | |
| Weighted average by Cap. | -0.58% | +2.48% | +39.76% | +84.80% |
Employees
-
Sector
Pharmaceuticals
















